Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis

Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis

Background: Dimethyl fumarate (DMF) is an oral systemic agent approved for the treatment of moderate-to-severe psoriasis vulgaris. It has a favourable tolerability profile, but it is associated with a high incidence of mild and reversible adverse events. The aim of the article is to describe a clini...

Full description

Bibliographic Details
Main Authors: Giovanna Malara, Gabriella Fabbrocini, Caterina Trifirò, Martina Burlando
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2021-05-01
Series:Drugs in Context
Subjects:
dimethyl fumarate
plaque psoriasis
systemic conventional treatment
Online Access:https://www.drugsincontext.com/dimethyl-fumarate-titration-for-the-systemic-treatment-of-moderate-to-severe-plaque-psoriasis

Internet

https://www.drugsincontext.com/dimethyl-fumarate-titration-for-the-systemic-treatment-of-moderate-to-severe-plaque-psoriasis

Similar Items